New Paradigms in the Treatment of Wet AMD: The Impact of anti-VEGF Therapy

This supplement was supported by Novartis Pharmaceuticals Limited (UK). The company has had the opportunity to comment on the medical content and accuracy of the article; however, final editorial content resides with the authors and the journal. The authors thank Sue Harris from Huntsworth Health, who provided medical writing support on behalf of Novartis Pharmaceuticals.